• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

FDA announces updates to Medtronic’s Class I recall for SynchroMed drug pumps

March 14, 2017 By Sarah Faulkner

FDA updates Medtronic's Class I recall for SynchroMed drug pumpsThe FDA today updated Medtronic’s Class I recall for the company’s SynchroMed II and SynchroMed EL implantable drug pumps, which were designed to locally treat primary or metastatic cancer, chronic pain, and severe spasticity.

The pumps were recalled in 2013 because they unintentionally delivered drugs during the priming bolus procedure and patients were at risk for overinfusion in the cerebrospinal fluid followed by a period of reduced drug delivery.

In October last year, Medtronic said that the SynchroMed II implantable drug pump was linked to more than 100 adverse events including 2 previously unreported deaths. The Fridley, Minn.-based company eventually agreed to halt the manufacture of the SynchroMed II pump after years of problems with the device.

As of July 5, 2016, there were 103 incidents of overinfusion among the more than 238,000 SynchroMed II pumps implanted since the device came to market.

“Medtronic has been unable to establish a definitive causal relationship between the adverse events and overinfusion due to potential contributing factors. However, it is reasonable to conclude that overinfusion was a contributing factor in these cases,” the company said in a letter. “While the full drug history of these pumps is unknown, 99 of the 103 pumps were associated with non-indicated drug formulations in use at the time of the pump’s last refill.”

The updated Class I recall affects SynchroMed II and SynchroMed EL implantable drug infusion pumps manufactured from Sept. 2013 to Oct. 2016 and includes 14,499 Model 8870 software application cards.

The company’s updated communications said that Medtronic made a software change to the SychroMed II application on the Model 8870 software application card.

“The change will correct the priming volume associated with the priming bolus function,” the update said.

Representatives from Medtronic began visiting customers in October last year to replace software application cards with the updated version, according to the updated communication.

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Wall Street Beat Tagged With: Medtronic

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

Reader Interactions

Comments

  1. Kristin says

    November 3, 2018 at 10:15 pm

    I have one of the recalled pumps inside of me and just found out by self discovery. It’s was recalled in 2013, however wasn’t put into me until 10/2015. I’m furious!!! No one from Medtronic has contacted me.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS